Change in Management: Exyte announces Katrien Verlinden as new President of its Global Business Unit Advanced Technology Facilities PressReach · Apr 2, 2025
So-Young International Inc. Announces Share Purchase by Controlling Shareholder PressReach · Apr 2, 2025
Dizal Announces DZD8586 and DZD6008 Presentations at 2025 ASCO Annual Meeting PressReach · Apr 1, 2025
IgniteData Advances Clinical Trial Efficiencies with Successful Deployment at Leading Cancer Center PressReach · Mar 31, 2025
SCORE analysis of semaglutide 2.4 mg demonstrated risk reduction in cardiovascular events in a real-world setting PressReach · Mar 31, 2025
Akeso's 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape with Bispecific Antibodies PressReach · Mar 31, 2025
Ozempic® (semaglutide) injection 1 mg showed improved functional outcomes and health-related quality of life in Phase 3 STRIDE trial in adults with type 2 diabetes and peripheral artery disease (PAD) presented at ACC 2025 PressReach · Mar 30, 2025
WELL Health Announces Delay in Filing of Annual Audited Financial Statements Due to Matter Related to US Subsidiary Circle Medical PressReach · Mar 29, 2025
